This study analyzes the importance of the source and rate of ATP production (glucose flux, glycogenolysis, and oxidative phosphorylation) in the prevention of ischemic contracture in isolated rat hearts. Ischemic contracture was initiated at about 10 minutes by buffer perfusion with nonglycolytic substrates whereas the addition of 11 mM glucose prevented contracture for 2 hours. Tissue values of ATP, phosphocreatine, and lactate could be dissociated from onset of ischemic contracture. In hearts perfused with acetate or free fatty acid, with 11 mM glucose, glycolytic ATP production was 2.3-2.8 ,umol/g fresh wt/min; as initial rates of glycogenolysis fell, glycolysis was maintained by a steady increase of glucose flux to values in excess of 2 ,tmol ATP/g fresh wt/min. Decreasing the glucose flux by lowering the perfusate glucose or by the addition of 2-deoxyglucose precipitated ischemic contracture. When oxidative phosphorylation was further reduced by hypoxia, glucose still prevented ischemic contracture; however, when oxidative phosphorylation dropped to near zero (near-anoxic) rates, glycolysis was inhibited, and glucose could only delay ischemic contracture to about 45 minutes. Combined ATP production rates could be dissociated from contracture. The metabolic parameter that correlated best with prevention or delay of ischemic contracture was the rate of glycolytic flux from glucose, which in this model of global low-flow ischemia had to accelerate to provide a rate of ATP production from glucose in excess of 2 ,imol/g fresh wt/min within 30 minutes of the start of ischemia to prevent ischemic contracture.
I schemic contracture is caused by either inadequate ATP, which cannot dissociate the actinmyosin cross bridges, or insufficient energy, which cannot restore resting cytosolic calcium levels.' Several workers have proposed a critical tissue level of ATP at which ischemic contracture develops. [2] [3] [4] [5] [6] [7] In contrast, others have dissociated tissue ATP levels from the development of contracture and have argued that glycolytic ATP production is of particular importance in the prevention of ischemic contracture. [8] [9] [10] A similar proposal has also been put forward for the maintenance of membrane function during ischemia.11-4 However, none of these authors has measured rates of glycolytic ATP production nor attempted to relate rates of glycolysis to the time of onset of ischemic contracture.
In this study we measured the rates of ATP production from glycolysis and from residual oxidative metabolism in rat hearts subject to global low-flow ischemia. Glycolytic ATP production was manipulated by 1) altering the perfusate glucose concentration and 2) replacing glucose by 2-deoxyglucose. Rates of oxidative phosphorylation were varied by manipulating perfusate Po2. We also examined the relative importance of tissue levels of ATP, phosphocreatine (PCr) and lactate, glucose flux, glycogenolysis, and mitochondrial ATP production in the prevention of lowflow ischemic contracture. The rate of ATP production from glucose was varied by altering the perfusateglucose concentration, by adding the glycolytic inhibitor 2-deoxyglucose, or by near-anoxic conditions. Our data allow us to hypothesize that a certain rate of production of glycolytic ATP from glucose is required for protection from ischemic contracture in subtotal global ischemia in isolated rat hearts and that ATP production from glycogenolysis is ineffective in the prevention of ischemic contracture.
Materials and Methods

Perfusion Techniques
Hearts (0.9-1.1 g fresh weight) from male Long-Evans rats (250-300 g) were perfused by the Langendorff technique with Krebs-Henseleit buffer (2.5 mM Ca2+, 5.9 mM K', 5 mM acetate with 0-11 mM glucose and other substrates as in text) equilibrated with a mixture of 95% 02-5% CO2 or 95% N2-5% CO2 and maintained at 370 C. During the 5-minute stabilization period and during the 10-minute control period, the perfusion medium was delivered to the heart at a perfusion pressure of 66 mm Hg (about 10 kPa). Subtotal global ischemia was created by reducing the coronary flow from control values of about 10-14 ml/min to 0.5 ml/min by use of a constant flow pump, which maintained a steady rate of flow even as contracture developed (for evidence of ischemia, see Reference 11); ischemia plus hypoxia was produced by gassing the perfusate with 95% N2-5% CO2 (arterial Po2<30 mm Hg), and ischemia plus near-anoxia was produced by both gassing the perfusate with 95% N2-5% CO2 and surrounding the heart with 95% N2-5% CO2. Exclusion Criteria Hearts with coronary flow above 14 ml/min, an irregular heart beat, a heart rate less than 200 beats/min, or an active tension of less than 6 g were eliminated during the control period.
Mechanical Measurements
A force displacement transducer (model FTO3C, Grass Instrument, Quincy, Massachusetts) was attached to the apex of the heart to measure contractile force. The minimum resting tension (maximum 1 g) was applied to the heart to create a peak contractile force (difference between peak systolic and resting diastolic tension) of between 6 and 8 g in all cases. Immediately after the onset of low-flow ischemia, active tension increased by 10-20% and then fell rapidly (within 30 seconds) to less than 2 g. Regular systolic activity was often not present during low-flow ischemia with only an occasional beat interrupting the resting diastolic tension.
Measurement of Ischemic Contracture
Ischemic contracture was taken as the initial rise in diastolic tension after the onset of ischemia (Figure 1 of Reference 3). The percent of ischemic contracture (rise in diastolic tension) was calculated by using the peak contractions (systolic-diastolic tension) during the control period as 100%. 8 The time course of the contracture usually showed a characteristic sigmoidal shape. The start of ischemic contracture was defined as a 5% rise in the diastolic tension. Tissue Metabolite Analysis Hearts were freeze-clamped between aluminum tongs precooled to the temperature of liquid nitrogen and freeze-dried before being extracted in cold perchloric acid (0.5 M) for analyses of ATP, PCr, and lactate."
Estimation of Glucose Flux and Glycogenolysis
Glucose flux was measured by the formation of 3H2O from D-[2-3H]glucose as described by Neely et a115 and Rovetto et al.16 Lactate not accounted for by glucose utilization was assumed to come from the breakdown of glycogen. Critical to this assumption was the finding that, during ischemia in the presence of acetate, the input of carbohydrate into the tricarboxylate cycle was negligible because, even allowing for isotope dilution from unlabeled glycogen mobilization, carbohydrate oxidation (measured by 14CO2 production) was less than 0.07±0.02 ,mol ATP/g fresh wt/min (n=9). This represents less than 3% of the total oxidation rate as calculated from the oxygen uptake.
Measurements of Mitochondrial Metabolism
Mitochondrial ATP production was estimated from either the oxidative decarboxylation of U-[14C]-labeled substrates or the oxygen uptake. When 14CO2 production was assayed, 1-ml samples were taken from the cannula in the pulmonary artery and immediately injected into a sealed container. 1'CO2 was released by reducing the pH to 5.3 and trapped in a disposable center well containing 0.3 ml phenylethylamine. Samples were counted using 10 ml scintillation fluid (Ready Solv HP, Beckman Instruments, Inc, Fullerton, California) in a counter (Packard Instrument, Meriden, Connecticut). Appropriate corrections were made for quenching.
Oxygen uptake was calculated from arteriovenous tension differences11,17 with direct sampling from a cannulated pulmonary artery. To convert 02 uptake to total ATP production, it was assumed that respiration remained coupled during low-flow ischemia18 and that glycolysis made no contribution to oxidative phosphorylation in the presence of acetate or 0.5 mM palmitate bound to 0.1 mM albumin (FFA). The incoming oxygen tension of the perfusate was between 550 and 600 mm Hg for hearts perfused with 95% 02 and less than 30 mm Hg for hearts perfused with 95% N2. Arteriovenous differences for oxygen tension were consistently between 500 and 550 mm Hg for ischemic hearts and undetectable for hearts exposed to ischemia plus hypoxia or near-anoxia. Calculation ofATP Production From Glycolysis and Oxidative Phosphorylation ATP production from glycolysis was calculated by using 2 ATP/mol glucose and 3 ATP/mol C6 glucose as equivalents for glycogen. ATP production from oxidative phosphorylation using 'C-labeled substrates was calculated by using 36 ATP/mol glucose, 10 ATP/mol acetate, and 129 ATP/mol palmitate.19 ATP production from oxidative phosphorylation was calculated from oxygen uptakes by assuming a phosphorylation/oxidation ratio of 2.5 for acetate and 2.8 for palmitate and triglyceride.20 The triglyceride contribution to oxidative phosphorylation was oxygen that was not accounted for by either acetate nor palmitate, with an assumed ratio of about 50:50 between triglyceride plus acetate or triglyceride plus palmitate. Thus, in the hypoxia and near-anoxia experiments, in which oxygen uptake was undetectable, triglyceride oxidation was assumed to be equal to the oxidation of either acetate or palmitate, the latter being measured by 14CO2. The contribution of triglyceride to total ATP production in hypoxia plus ischemia experiments was 10% or less and in the ischemia plus near-anoxia experiments was 4% or less. The maximum possible values were taken into account in the calculation.
Presentation of Data
Results are expressed as mean-+SEM, with n= number of hearts. Values of p were calculated by Student's t test. When several groups were compared with a single group, the data were first analyzed with a one-way analysis of variance followed by Dunnett's test. A value ofp <0.05 (two-tailed test) was regarded as significant.21 Myocardial tissue levels of ATP, PCr and lactate, and ATP production rates were expressed in terms of fresh heart weight (dry weightx5).
Results
Substrates, Ischemic Contracture, and High Energy Phosphates
Mechanical performance. Before ischemia, there was no difference between the groups for either the resting tension (acetate, 0.63+±0.07 g, n=8; acetate plus 11 mM glucose, 0.65-+0.04 g, n=19) or peak contractile force (acetate, 7.03-+±0.24 g, n=8; acetate plus 11 mM glucose, 7.10±0.18 g, n=19). Heart rates before ischemia were similar (acetate, 284+16 beats/ min; acetate plus 11 mM glucose, 293+8 beats/min).
After the onset of ischemia, there was no difference in systolic contractile force (acetate, 0.9+±0.3 g at 5 minutes and 0.8+0.3 g, n=8, at 10 minutes; acetate plus 11 mM glucose, 0.5+0.2 g, n=19, at 10 minutes after the onset of ischemia) or the time to initial cessation of systolic function (acetate, 8.9±1.9 minutes vs. 5 mM acetate plus 11 mM glucose, 8.5+1.0 minutes).
Effect ofglucose on the time to ischemic contracture. Ischemic hearts perfused either with no external substrate or with nonglycolytic substrates such as acetate, FFA, 5 mM lactate, or 5 mM pyruvate developed ischemic contracture within 10 minutes ( Figure 1 ). When ischemic hearts were perfused with acetate and increasing concentrations of glucose (2, 4, 6, 8 . 5% ischemic contracture is increase in diastolic tension to 5% of the peak systolic tension.
For preischemic values for Ace and Ace+ 11 mM Glu, see Figure 3 .
*p<0.005 vs. Ace+11 mM Glu (120-minute value). tp<0.05 vs. Ace+11 mM Glu (120-minute value). tp<0.05 vs. Ace (ischemic time only).
progressively and significantly delayed as the glucose concentration rose (Figure 2 , Table 1 ). Glucose (11 mM) prevented the onset of contracture for more than 2 hours; 8 mM glucose delayed the onset beyond 30 minutes, 6 mM glucose delayed the onset to 21±2 minutes, 4 mM glucose delayed the onset to 17±2 minutes, 2 mM glucose delayed the onset to 15±2 minutes, and with 0 mM glucose onset of contracture was at 10 minutes with a peak value of 120±7% after only 20 minutes. Changes in tissue levels of ATP, PCr, and lactate during ischemia (Figure 3 ). The levels of ATP, PCr, and lactate were followed during ischemia with either acetate or acetate plus 11 mM glucose as substrate. In hearts perfused with acetate alone, an ATP concentration of 2.8±0.2 gmol/g fresh wt was found at the onset of contracture. However, in hearts perfused with acetate plus 11 mM glucose (no ischemic contracture after 2 hours of ischemia), there was a higher ATP level of 3.1±0.23 ,umol/g fresh wt at 10 minutes, a similar ATP level at 30 minutes, and a lower ATP level of 1.7±0.05 ,umol/g fresh wt after 2 hours of ischemia. PCr levels fell rapidly during the first 10 minutes of ischemia to 3.0 and 1.6 ,umol/g fresh wt in hearts perfused with acetate and acetate plus 11 mM glucose, respectively; the levels thereafter were little changed. Tissue lactate was about double in hearts perfused with acetate and 11 mM glucose at 120 minutes when compared with acetate alone at 10 minutes (13.9±0.1 gmol/g fresh wt and 7.2±0.9 ,gmol/g fresh wt, respectively, p<0.001).
Tissue ATP, PCr, and lactate at the start of contracture (Table 1, Figure 3 ). Tissue ATP was measured at the onset of contracture with no external substrate and nonglycolytic substrates (FFA, lactate, pyruvate, and acetate). ATP levels ranged from 2.4+0.8 to 3.3 +0.12 ,umol/g fresh wt (average, 2.98 +0.08 ,tmol/g fresh wt, n =29) with exposure to ischemia between 8 and 12 minutes (Table 1) . When glucose was added to the acetate in increasing amounts (2, 4, and 6 mM glucose), onset of contracture was progressively delayed while the tissue ATP at the onset of contracture was unchanged.
When hearts were perfused with acetate or palmitate and when ischemia was combined with nearanoxia, 11 mM glucose delayed the onset of contracture from 10±1.5 minutes in the case of acetate alone to 41±3 minutes, and from 10±1.1 minutes in the case of palmitate alone to 45 +6 minutes. The respective tissue ATP levels at the time of onset of contracture were as follows: glucose plus acetate, 1.4+0.18
,umol/g fresh wt; glucose plus palmitate, 1.6+0.1 ,umol/g fresh wt. Thus, there appeared to be no direct relation between the time to onset of contracture and the level of tissue ATP.
There was no connection between the drop in PCr levels and the rise in diastolic tension. At 5% ischemic contracture, tissue PCr values ranged from 0.5 to 3.1 ,umol/g fresh wt with the lowest values found in the near-anoxic hearts.
Tissue lactate levels could also be dissociated from the onset of ischemic contracture since both low (3.5±+ 0.13 ,umol lactate/g fresh wt) and high (23.9+1.39 ,umol/g fresh wt) levels were found at the onset of contracture.
Rates of glucose flux and glycogenolysis during ischemia with acetate and 0-11 mM glucose (Table 2, Figure 4 ). During acetate perfusion, when the concentration of glucose was increased in a stepwise manner, acetate oxidation was not affected, the rates of glycogenolysis were minimally reduced, and the glucose contribution to glycolysis increased in proportion to glucose concentration. In addition, the contribution of 8 and 11 mM glucose to glycolysis increased as ischemia progressed. Steady values of glucose flux in hearts perfused with 11 mM glucose 5A. were only achieved 30 minutes into the ischemic period. The combined ATP production from glucose, glycogen, and acetate at the onset of contracture in these hearts was between 3.4 and 3.7 ,umol ATP/g fresh wt/min. Hearts perfused with acetate plus 11 mM glucose exhibited no ischemic contracture for 2 hours and were able to increase glucose flux within 30 minutes of ischemia to a steady rate of ATP produc- after acetate (Ace) perfusion at onset of ischemic contracture or after 120 minutes if no contracture developed. ATP from glucose (Glu) was measured from formation of 3H20 from [3H]Glu. ATP from glycogen (Gly) was calculated from the lactate efflux not accounted for by Glu flux. ATP from Ace was measured from the formation of 1'4CO2 from [14C]Ace. Preischemic values for ATP production in hearts perfused with Ace+ 11 mM Glu: oxidation of Ace 11.5 ±0.07 (10) , oxidation of Glu 0.07±0.06, and Glu flux (glycolysis) 0.5±0.06 (10) ,umol/g fresh wt/min (glycogenolysis was not measured). n=6-10 in all experiments. *p<0.005 vs. Ace+ 11 mm Glu. tion from glucose of about 2 ,gmol/g fresh wt/min for the remaining duration of ischemia. In contrast, hearts perfused with 6 mM glucose and less were all unable to reach and maintain this rate of glucose flux and consistently developed ischemic contracture; the lower the external glucose concentration, the less was the contribution of glucose to glycolysis, and the sooner the onset of ischemic contracture.
Perfusions with FFA ( Figure 5 ). The rate of ATP production from oxidation of FFA and from glycolysis was measured in ischemic hearts perfused with FFA or FFA plus 11 mM glucose, the latter in the presence of hypoxia or near-anoxia, to reduce the rate of mitochondrial oxidative phosphorylation. Ischemic hearts perfused with FFA alone developed contracture at about 10 minutes (Figure 1 ) despite having a high ATP production rate of 3.5+±0.4 ,mol ATP/g fresh wt/min from glycogenolysis and 0.98±0.06 ,umol/g fresh wt/min from FFA, which together made a total of about 4.5 ±0.4 ,umol/g fresh wt/min. When FFA oxidation was reduced from about 1.0 to 0.4 gumol ATP/g fresh wt/min by hypoxia, the addition of 11 mM glucose prevented ischemic contracture for 60 minutes. ATP production from glucose increased steadily from 1.16 (10 minutes) to 2.1 (30 minutes) ,umol/g fresh wt/min, while ATP production from glycogenolysis fell from 1.69 (10 minutes) to 0.67 (30 minutes) gmol/g fresh wt/min. In these hearts, the combined ATP production from FFA oxidation and glycolysis was steady at about 3.2 gmol/g fresh wt/min over the 60-minute period.
When near-anoxia was introduced, there was a further reduction of FFA oxidation to less than 0.1 ,umol ATP/g fresh wt/min. In such conditions, the addition of 11 mM glucose delayed but could not prevent ischemic contracture. ATP production from FFA and glycolysis failed to reach the values found in the previous hearts (hypoxia) and fell from 2.5 to 1.5 ,umol ATP/g fresh wt/min (40-minute value) when ischemic contracture occurred. Glucose flux initially rose to a maximum of 1.4 ,umol/g fresh wt/min at 30 minutes but was falling as ischemic contracture developed at about 45 minutes; glycogenolysis fell steadily from 1.3 to 0.3 ,umol/g fresh wt/min during the 60-minute experiment.
Calculated rates ofATP production including intracellular sources ( Table 3 ). In hypoxic or near-anoxic hearts, no arteriovenous differences for oxygen could be detected, and rates of oxidative phosphorylation were calculated from 14CO2 release (see "Materials and Methods"). In addition, the rate of fall of ATP and PCr in the myocardium was calculated. Ischemic hearts perfused with acetate and 11 mM glucose with an incoming "arterial" Po2 greater than 550 mm Hg had a total ATP production of 6.1 ,umol/g fresh wt/min for the first 10-minute period followed by a steady rate of 4.8-5.0 ,umol/g fresh wt/min. Contributions from the different sources reached a steady state by about 60 minutes when the rate of ATP production from glycogen was low and the rate from glucose was high. In ischemic hearts perfused only with acetate (arterial Po2>550 mm Hg), the total ATP production in the first 10 minutes was 5.1 ,umol/g fresh wt/min but was falling rapidly at the time of ischemic contracture (10-minute value, 4.6 ,umol/g fresh wt/ min). In hearts perfused with FFA plus 11 mM glucose in the presence of hypoxia (arterial Po2<30 mm Hg), total ATP production was approximately 4.6 gmol/g fresh wt/min for the first 20 minutes and fell to a steady mean rate of 3.8 ,umol/g fresh wt/min for the 60-90-minute period. In hearts perfused with FFA plus glucose in the presence of near-anoxia (FFA oxidation<0.1 gmol ATP/g fresh wt/min), total ATP production was 4.0 gmol/g fresh wt/min in the first 10-minute period and fell to about 1.8 ,umol/g fresh wt/min before the onset of ischemic contracture. Glycolytic inhibition (Figure 6 ). Ischemic hearts were perfused with acetate and 11 mM glucose for 15 minutes, and then the glucose was replaced by 11 +G, 11 mM glucose; -G, absence of glucose; PCr, phosphocreatine; FFA, 0.5 mM palmitate bound to 0.1 mM albumin; Hy, hypoxia; An, anoxia. ATP units were ,umol/g fresh wt/min (total rates over a 10-, 30-, or 60-minute period). ATP from glucose was measured from formation of 3H20 from [3H]glucose. ATP from glycogen was calculated from the lactate efflux not accounted for by glucose flux. ATP from either acetate or FFA was measured from the formation of 14C02. ATP from triglycerides was calculated from the oxygen uptake not accounted for by oxidation of acetate or FFA. ATP production at onset of contracture (no glucose) at 10 minutes for hearts perfused with only acetate was 4.6 ,umol/g fresh wt/min; ATP production at onset of contracture (anoxia) at 45 minutes for hearts perfused with FFA+glucose was 1.7 ,mol/g fresh wt/min. mM 2-deoxyglucose while acetate was continued. Ischemic contracture developed 5.1 ±+0.3 minutes (n=6) after the introduction of 2-deoxyglucose (tissue ATP, 2.08+0.12 ,umol/g fresh wt). Addition of 2-deoxyglucose and omission of glucose inhibited glucose flux ( Figure 6 ), which fell rapidly concurrent with the onset of contracture. Rates of glycogenolysis were unchanged by 2-deoxyglucose when compared with control hearts (Figure 6, panel B) . Acetate oxidation was stable throughout the experimental period with rates between 1.2 and 0.8 ,umol/g fresh wt/min of ATP being formed.
Discussion
Our data show that ischemic contracture in lowflow ischemia consistently developed when nongly- FIGURE 6. Graphs showing effect of the glycolytic inhibitor 2-deoxyglucose on development ofischemic contracture and ATP production. Hearts were perfused with acetate for the duration ofthe experiment.
Panel A: Glucose (11 mM) was replaced with 2-deoxyglucose (11 mM) after 15-minute ischemia. Panel B: Glucose (11 mM) was used for the whole experiment (n=6-10 for each group). Striped area indicates ATP production from oxidation of acetate (-A); open area between dots and stripes indicates ATP production from glycogen (a-_) (glycogenolysis); dotted area indicates ATP production from glucose (o-o) (glucose flux). 0 5 10 15 20 25 30 Ischemic mins colytic substrates were provided or when glucose flux was decreased or inhibited by several procedures including 1) introduction of low external concentrations of glucose, 2) creation of near-anoxic conditions, or 3) addition of 2-deoxyglucose. All these procedures decreased the production rate of glycolytic ATP from glucose. Like Bricknell and colleagues8,1' and Lipasti et al,9 we were able to dissociate changes in levels of tissue ATP from the development of ischemic contracture (Table 1 ). We also showed that provision of glucose during low-flow ischemia delayed the onset of ischemic contracture, although the tissue ATP level fell to lower values than those found at onset of acetate-induced contracture. The values of ATP at the onset of ischemic contracture were too high for the development of rigor2 unless there was substantial subcellular compartmentation of ATP. A severe decline in the free energy of ATP during ischemia can be excluded. 22 Definition of Ischemic Contracture Our definition of the onset of ischemic contracture, namely a rise of diastolic tension during the ischemic period, corresponds with that used by Humphrey et a16 and Lipasti et al. 9 Hearse et a13 referred to the historical origin of the term "ischemic contracture," which in its extreme form is the "stone heart." They also defined the onset of ischemic contracture as an elevation of the recorded diastolic pressure (Figure 1 of Reference 3). Apstein et al12 showed that the rise in diastolic pressure was followed in the reperfusion period by a decreased developed pressure with lower values for positive and negative maximum dP/dt. Other methods of measuring ischemic contracture include sonomicrometry, which shows that an increase in wall thickness and a decrease in the minor axis occur at about the same time as the increase in diastolic pressure. 23 There also seems to be a relation between ischemic contracture in animal models to decreased diastolic compliance,12 which raises the speculative possibility of a further relation between impaired intracellular energy provision from glucose and the diastolic mechanical abnormalities found in angina pectoris. 24 
ATP and Ischemic Contracture
Several reports indicate that the source and turnover of ATP are more important than the concentration of ATP in the prevention of ischemic contracture9-1",25 and in the maintenance of normal contractile activity.26 Therefore, we calculated rates of ATP production from glycolysis (glucose and glycogen) and from residual mitochondrial metabolism (Tables 2 and 3 , Figures 4 and 5 ). There were no significant differences when ischemic contracture developed in the combined ATP production nor in the rate of ATP production from glycolysis (glucose plus glycogen) in ischemic hearts perfused with an arterial Po2 of greater than 550 mm Hg when compared with those that did not (Figure 4 , Table 2 ).
Even when allowing for ATP synthesized by endog-enous substrates and for the breakdown of tissue stores of ATP and PCr (Table 3) , no clear relation could be established between total rates of ATP synthesis and the presence or absence of ischemic contracture. Rather, the consistent distinguishing feature of those hearts that did not develop ischemic contracture was the presence of external glucose, which was generally associated with rates of production of ATP from glucose of about 2.0 ,umol ATP/g fresh wt/min or somewhat higher (Figure 4 ).
Rates of Glucose Flux
The novel aspects of our data relate not only to the requirement for glycolytic flux from glucose rather than from glycogen to prevent ischemic contracture but also to quantification of the rate of ATP production from glucose that is required. Support for these concepts comes from the data of Apstein et al,12 who did not directly measure glycolytic flux but did prevent the onset of contracture in moderately ischemic rabbit hearts by doubling the rate of lactate production during increased provision of glucose (when the perfusion concentration increased from 5.5 to 27.5 mM) and the addition of insulin.
However, some of our data may seem not to be consonant with our proposal that minimal rates of glucose flux are required to prevent contracture. Specifically, during early ischemia (10-minute values), hearts perfused with acetate plus 11 mM glucose or hypoxic hearts perfused with FFA plus 11 mM glucose had rising glucose flux rates that were almost identical to the falling rates of glucose flux at the delayed (45-minute) but definite onset of ischemic contracture found in near-anoxic hearts perfused with FFA plus 11 mM glucose. These rates of glucose flux were low, below 1.2 gmol/g fresh wt/min (Table 3 ); yet, during early ischemia there were other sources of ATP available (such as stores of ATP, PCr, and oxidative phosphorylation) so that the total ATP production was much higher in these hearts than in the near-anoxic hearts (see Table 3 and Figure 5 ). Therefore, during early ischemia (0-10 minutes), the hypothesis that glucose flux protects from ischemic contracture by provision of glycolytic ATP must be modified to allow for the relative contribution of glucose flux to be dependent on the availability of ATP from other source.
Inhibition of Glycolysis
Glycolysis may be inhibited during severe ischemia, especially with the creation of anoxic conditions, by 1) an increase in cytosolic NADH2, 2) insufficient ATP for glucose phosphorylation and entry into glycolysis,27-29 and 3) high tissue levels of lactate and HW.16 For glycolysis to be beneficial to the ischemic myocardium, there could be a certain minimal coronary flow rate required to avoid the inhibition of glycolytic flux caused by very severe ischemia when glycolysis fails to inhibit contracture. 12 Theoretically, accumulation of tissue lactate should limit the benefits of glycolysis. Neely and Grotyohann30 proposed that a high tissue lactate level formed during total ischemia in the isolated rat heart could lessen recovery during reperfusion; nonetheless, these conclusions could not be confirmed by Lagerstrom et a131 nor in our data (Table 1) . Hence, it would seem unlikely that the accumulation of tissue lactate, at least to modest levels (e.g., 14 ,umol/g fresh wt, Table 1 ), could be regarded as a harmful effect of glycolytic flux. In the anoxic glucose-free rat heart, an accumulation of lactate could be dissociated from the development of contracture. 32 A further question is whether the higher tissue lactate levels in the hearts perfused with acetate and glucose when compared with those perfused with acetate alone could have reflected higher rates of proton production, thereby inhibiting ischemic contracture. 33 However, as analyzed by Gevers,34 increased rates of glycolysis do not, per se, result in proton production; rather, such production of protons is only achieved when ATP is simultaneously broken down. Therefore, direct measurements of tissue pH would be required to explore this possibility further.
Glucose Flux Versus Glycogenolysis
High rates of total glycolytic flux did not always protect from ischemic contracture, notably when hearts perfused with acetate or FFA alone had high rates of glycogenolysis ( Table 2, Figures 4 and 5 ). There may be some justification for supposing that glycolytic flux from glucose is more beneficial to the ischemic myocardium than flux from glycogenolysis, even at similar rates of production of glycolytic ATP. In regionally ischemic hearts, increased glucose flux can be related to decreased rates of release of enzyme from the heart. 35 In contrast, the proposed harmful effect of glycolytic flux in the experiments of Neely and Grotyohann30 were in fact associated with glycogen breakdown, not with glucose flux. In perfused interventricular septa, Runnman and Weiss36 showed that high-energy phosphates derived from glycogen were less effective than those derived from exogenous glucose in preserving cardiac function during hypoxia. In addition, Allen37 has proposed that the acidosis associated with lactic acid production from glycogen stores could increase intracellular free calcium. In general, our study showed glycogen breakdown was higher in hearts that developed ischemic contracture than in those that did not (Figure 4) . A notable exception was the group of hearts perfused with FFA and glucose in near-anoxic conditions in which the overall glycogen breakdown was lower than in hearts in hypoxic conditions. However, it should be noted that ATP production from all available sources was decreased ( Figure 5 ).
There is also some support from subcellular studies for the concept that glucose flux may benefit the ischemic myocardium more than flux from glycogen. During limited ATP supply in liver cells, enzymes with a greater average distance from the mitochondria (e.g., plasma membrane ATPases) suffer from a more marked decrease in the ATP concentration to which they are exposed than do enzymes close to mitochondria (e.g., cytoplasmic enzymes).38 There is also evidence for the association of glycolytic complexes to ATP-sensitive K' ion pumps in the cardiac sarco-lemma14 and for links between glycolysis and calcium uptake in the smooth muscle plasma membrane. 39 In the myocardium, glycogen is mainly concentrated along the mitochondrial columns in the perinuclear sarcoplasm and near the sarcoplasmic reticulum,40 and a glycogenolytic-sarcoplasmic reticulum complex has been shown to exist.41 Hence, a speculative proposal is that ATP production from glycogenolysis in or near the sarcoplasmic reticulum may be less effective than glycolysis from glucose in maintaining calcium homeostasis across the sarcolemma.
Intracellular Calcium
Direct links between ischemic contracture and cytosolic calcium in the whole heart still need to be established chiefly because of technical problems in measuring and correctly interpreting the data.38 Values of total tissue and of mitochondrial calcium rise during ischemic contracture. 42, 43 In isolated rat myocytes, metabolic inhibition increased cytosolic calcium before the onset of contracture.33 In ischemic papillary muscle obtained by superfusing with N2-CO2, an increase of cytosolic calcium, measured by aequorin, was found before ischemic contracture. 44, 45 Reservations
The first reservation is that glucose flux was measured isotopically by the rate of formation of tritiated water whereas glycogenolysis was measured indirectly from formation of lactate not accounted for by glucose flux. The rates of diffusion of 3H20 and lactate from the cell may differ, especially during early ischemia when glucose flux is increasing and glycogenolysis is decreasing. Alternative measurements of glycogenolysis by cardiac glycogen levels are difficult because of the variability of the glycogen level in the rat heart.
A second reservation is that our data relative to tissue metabolites and ATP production rates sample the whole heart without distinction between epicardium and endocardium. The onset of ischemic contracture was monitored by a force transducer connected to the epicardium. Ultrastructural evidence shows that all damage begins in the endocardium and progresses towards the epicardium. 35, 46 Our electron microscopic data from endocardial tissue show that the early phases of ischemic contracture are highly focal and that small groups of affected myocytes may be surrounded by large zones with normal ultrastructure. 47 Whole heart tissue ATP levels are unlikely to reflect the level in individual affected myocytes. However, it may be noted that in the studies of Apstein et a112 ischemic contracture, monitored by a ventricular balloon, was also delayed by glucose flux.
A third reservation is that cytosolic calcium levels were not measured; the exact mechanism for the onset of contracture remains to be defined.
Finally, we have not proven the mechanism whereby an increased glucose flux acts beneficially. However, we favor the view that glucose is able to produce ATP at a critical rate in proximity to the sarcolemma and, thereby, to maintain calcium homeostasis.
In conclusion, despite the above reservations, our data show that glucose flux consistently delayed or prevented the onset of ischemic contracture. It is proposed that a certain minimal rate of production of glycolytic ATP (about 2 ,umol/g fresh wt/min; Figures 4 and 5, Table 2 ) from glucose may be required to maintain internal calcium homeostasis. Because a steady state of glucose flux was not reached until 30 minutes after the onset of ischemia, we cannot exclude a requirement for other flux rates within the first 30 minutes of ischemia. The processes requiring ATP may be the uptake of Ca21 into the sarcoplasmic reticulum or Ca2' extrusion either by an ATPdependent Ca21 pump or by an exchange mechanism ultimately dependent on the Na+ pump.
